Pfizer Resubmits Thousands Of Adverse Chantix Reports
The U.S. Food and Drug Administration said Thursday that Pfizer Inc. last year resubmitted thousands of adverse event reports over its anti-smoking drug Chantix at the regulator's request....To view the full article, register now.
Already a subscriber? Click here to view full article